Showing results (71-80 of 76) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Blood|December 31, 1997
FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapyT Valerius, B Stockmeyer, A B van Spriel, et al.Leukemia|June 1, 1996
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92S Schlieben, A Borkhardt, I Reinisch, et al.Annals of Hematology|August 29, 2012
Current treatment of mantle cell lymphoma: results of a national survey and consensus meetingM Witzens-Harig, G Hess, J Atta, et al.Leukemia|June 5, 2012
The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cellsP Glorius, A Baerenwaldt, C Kellner, et al.British Journal of Cancer|December 17, 2003
Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancerR Repp, H H van Ojik, T Valerius, et al.Leukemia|November 3, 2015
Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the Study Alliance LeukemiaC Müller-Tidow, P Tschanter, C Röllig, et al.Pageof 8